subscribeSubscribe
Amarin Applauds Petition Urging FDA Fenofibrate Action

Amarin Applauds Petition Urging FDA Fenofibrate Action
GLOBENEWSWIRE
24 Apr 2024
Share Share
Amarin Announces Results of Annual General Meeting of Shareholders

Amarin Announces Results of Annual General Meeting of Shareholders
GLOBENEWSWIRE
22 Apr 2024
Share Share
Enforcement Report - Week of April 17, 2024

Enforcement Report - Week of April 17, 2024
FDA
17 Apr 2024
Share Share
Amarin Q1 2024 Results, Call On 5/1

Amarin Q1 2024 Results, Call On 5/1
GLOBENEWSWIRE
15 Apr 2024
Share Share
Amarin Highlights Key Data at ACC.24

Amarin Highlights Key Data at ACC.24
GLOBENEWSWIRE
08 Apr 2024
Share Share
New REDUCE-IT® Analyses Show VASCEPA Benefit in High-Risk Cardiovascular Disease

New REDUCE-IT® Analyses Show VASCEPA Benefit in High-Risk Cardiovascular Disease
GLOBENEWSWIRE
06 Apr 2024
Share Share
Amarin Provides Update on VAZKEPA® Intellectual Property Portfolio in Europe

Amarin Provides Update on VAZKEPA® Intellectual Property Portfolio in Europe
GLOBENEWSWIRE
03 Apr 2024
Share Share
Teva, like Hikma, accuses Amarin of hoarding Vascepa ingredient

Teva, like Hikma, accuses Amarin of hoarding Vascepa ingredient
Fraiser Kansteiner FIERCE PHARMA
30 Mar 2024
Share Share
Amarin to Report Fourth Quarter and Full Year 2023 Financial Results

Amarin to Report Fourth Quarter and Full Year 2023 Financial Results
GLOBENEWSWIRE
15 Feb 2024
Share Share
Enforcement Report - Week of February 14, 2024

Enforcement Report - Week of February 14, 2024
FDA
14 Feb 2024
Share Share